Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: J Thorac Oncol. 2016 Sep 28;12(2):223–234. doi: 10.1016/j.jtho.2016.09.129

Table 3.

Multivariable competing-risk regression model for any recurrence and lung cancer-specific death and Cox model for all-cause death

Any recurrence Lung cancer-specific death All-cause death



Variable SHR 95% CI p SHR 95% CI p HR 95% CI p
Age: >65 vs ≤65 -* - - -* - - 2.30 1.66, 3.20 <0.001

Sex: female vs. male -* - - 1.42 0.89, 2.29 0.14 -* - -

Smoking pack-year: >90 vs ≤90 1.53 1.01, 2.32 0.043 -* - - 1.34 0.99, 1.82 0.060

Pathological stage (vs Stage I)
 Stage II 1.59 0.98, 2.56 0.059 1.93 1.09, 3.43 0.025 1.11 0.79, 1.54 0.6
 Stage III 1.65 0.90, 3.02 0.11 2.53 1.26, 5.08 0.009 1.49 0.99, 2.24 0.057

Tumor size: per 1 cm increase 0.97 0.88, 1.07 0.6 1.01 0.92, 1.11 0.8 1.06 0.99, 1.13 0.094

Lymphatic invasion: present vs. absent 1.25 0.80, 1.96 0.3 1.35 0.76, 2.39 0.3 1.25 0.94, 1.66 0.13

Vascular invasion: present vs. absent 1.03 0.71, 1.49 0.9 1.10 0.67, 1.78 0.7 0.95 0.73, 1.24 0.7

Necrosis: present vs. absent 1.43 0.99, 2.07 0.060 1.37 0.85, 2.22 0.2 -* - -

Nuclear size: large vs. small 1.42 0.98, 2.04 0.063 1.37 0.87, 2.14 0.2 -* - -

Ki-67: ≥20% vs. <20% -* - - 1.90 0.72, 5.01 0.2 1.56 1.02, 2.40 0.040

Tumor budding: ≥10/HPF vs. <10/HPF 1.35 0.84, 2.17 0.2 1.87 1.02, 3.43 0.044 1.56 1.09, 2.25 0.016

Single cell invasion: present vs. absent -* - - 0.97 0.56, 1.67 0.9 1.34 0.99, 1.81 0.057

STAS: present vs. absent 1.50 1.03, 2.18 0.034 1.75 1.11, 2.75 0.016 1.12 0.85, 1.47 0.4

CI, confidence interval; HR, hazard ratio; SHR, sub-hazard ratio; STAS, spread through air spaces

*

variables with p-value >0.1 in univariable models were not analyzed in multivariable model